Primary Care

HIV & AIDS

Questions discussed in this category

How do you use CD4% in clinical practice in management of patients living with HIV?

7 Answers available

Would you consider using long-acting injectable cabotegravir/rilpivirine for pregnant women with HIV?

2 Answers available

What is your approach to anal pap screening among MSM with HIV, and if routinely recommend, starting at what age (assuming access to HRA)?

2 Answers available

How do you approach management for patient's with HIV on ART with persistent low level viremia but no new resistance mutations identified?

1 Answer available

What patient-specific factors would influence your decision to initiate semaglutide therapy in patients with HIV-associated lipohypertrophy?

1 Answer available

What is your approach to a positive PPD or IGRA in a patient with well-controlled HIV without significant TB risk factors?

3 Answers available

What steps do you recommend to ensure continued viral suppression and prevent drug resistance in an HIV patient on injectable cabotegravir and rilpivirine who misses their scheduled injection appointment by two weeks?

1 Answer available

Would you recommend starting a moderate-intensity statin in a patient under the age of 40 years old with HIV and a 10-year ASCVD risk estimate below 5%?

The REPRIEVE trial included participants who were between 40 and 75 years old.

1 Answer available

How do you counsel HIV patients with an undetectable viral load on breastfeeding?

2 Answers available

How do you apply the CDC PrEP guidelines for cisgender women, particularly when faced with underreported risk behaviors or uncertain partner HIV status?

1 Answer available

For patients on PrEP, is there a role for HIV RNA PCR screening in addition to 4th generation antigen/antibody testing?

1 Answer available

Given recent data from the REPRIEVE trial, how will you adapt your practice with regards to prescribing statins to patients living with HIV?

1 Answer available

Papers discussed in this category

The Journal of infectious diseases, 2007-12-15

Decreased adherence to antiretroviral therapy observed prior to transient human immunodeficiency virus type 1 viremia.

AIDS (London, England), 2021 Nov 01

HIV-1 viral blips are associated with repeated and increasingly high levels of cell-associated HIV-1 RNA transcriptional activity.

Current HIV/AIDS reports, 2023 Nov 13

Learning from Persistent Viremia: Mechanisms and Implications for Clinical Care and HIV-1 Cure.

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 1992 May 08

Guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2024 Dec 17

Long-Acting Injectable Cabotegravir and Rilpivirine in a Pregnant Woman With HIV.

HIV medicine, 2022 Nov 21

Pregnancy outcomes and pharmacokinetics in pregnant women living with HIV exposed to long-acting cabotegravir and rilpivirine in clinical trials.

Related Topics in Primary Care